Date Sent: 08/25/2016 04:33 PM EDT
Sender: Michigan Health Alert Network
Subject: Updated Recommendations from the CDC for the Influx of Fentanyl-laced Pills & Compounds
CDC has updated its recommendations for the Influx of Fentanyl-laced Counterfeit Pills and Toxic Fentanyl-related Compounds that further increases risk of Fentanyl-related overdose and fatalities
There has been new developments that have placed more people at risk for fentanyl-involved overdoses from IMF and may increase the risk of non-fatal and fatal overdose.
These developments include the following:
(1) a sharp increase in the availability of counterfeit pills containing varying amounts of fentanyl and fentanyl-related compounds (e.g., labeled as Oxycodone, Xanax, and Norco),
(2) the potential for counterfeit pills containing fentanyl and fentanyl-related compounds to be broadly distributed across the United States which could impact states not previously impacted by IMF and persons using diverted prescription pills (i.e., licit drugs diverted for illicit purposes and involves the diversion of drugs from legal and medically necessary uses towards uses that are illegal and typically not medically authorized or necessary),
(3) the widening array of toxic fentanyl-related compounds being mixed with heroin or sold as heroin, including extremely toxic analogs such as carfentanil, and
(4) continued increases in the supply and distribution of IMF.
CDC suggests the following actions in response to the increased risk of fentanyl overdose from IMF due to the influx of fentanyl-laced counterfeit pills, the widening array of highly toxic fentanyl-related compounds, and the continued expansion and geographic spread of the IMF supply:
1. Improve detection of fentanyl outbreaks to facilitate effective response.
Public health departments:
Medical examiners and coroners:
Law Enforcement: Law enforcement plays an important role in identifying and responding to increases in the distribution and use of illicitly manufactured fentanyl.
Laboratories: The following government forensic laboratories supporting law enforcement can provide assistance with reference materials or reference data on a case-by-case basis.
2. Expand Use of Naloxone and Treatment
Health Care Providers:
Harm reduction organizations:
For detailed CDC recommendations and additional information, review the attached CDC HAN message.
(This message is being sent to EMS, Emergency Preparedness, Lab, Local EPC, Health Officer, Medical Director and Healthcare)